Herbert Kim Lyerly
About Herbert Kim Lyerly
Herbert Kim Lyerly is a co-founder of Replicate Bioscience, Inc. and serves on the Board of Directors at OncoSec, with a long-standing academic career as a professor at Duke University School of Medicine since 1990.
Work at Replicate Bioscience, Inc.
Herbert Kim Lyerly serves as Co-Founder at Replicate Bioscience, Inc. since its establishment in 2020. In this role, he contributes to the strategic direction and development of the company, which focuses on innovative solutions in the field of bioscience. His extensive background in biomedical sciences and cancer research supports the company's mission to advance therapeutic options.
Current Role at OncoSec
Since 2020, Herbert Kim Lyerly has been a member of the Board of Directors at OncoSec. His involvement in this organization reflects his commitment to advancing cancer treatment through innovative technologies. His experience in the field informs the board's decision-making and strategic initiatives.
Academic Background and Education
Herbert Kim Lyerly completed his Bachelor of Science in Biomedical Sciences at the University of California, Riverside from 1976 to 1980. He furthered his education by obtaining a Doctor of Medicine (MD) from the University of California, Los Angeles between 1980 and 1983. He then pursued advanced studies at Duke University School of Medicine, where he specialized in Molecular Virology/Immunology as a Post-doctoral Fellow from 1985 to 1987.
Long-standing Academic Career at Duke University
Herbert Kim Lyerly has held a professorship at Duke University School of Medicine since 1990, where he is involved in the Departments of Surgery, Pathology, and Immunology. He has been recognized as the George Barth Geller Professor of Cancer Research since 2004. His academic role includes teaching, research, and mentoring students in the field of cancer research.